The Federal Reserve held interest rates steady but indicated that an increase was possible next month. The markets closed lower with the Dow dropping 77 points to 17,959. Nasdaq tumbled 48 points to 5,105.
On the upside
Skyline Medical (Nasdaq: SKLN) expanded its relationship with GLG Pharma to include exclusive marketing and distribution rights to Poland and other Central European countries.
Office Depot (Nasdaq: ODP) reported sharply higher third quarter earnings that beat expectations.
AveXis (Nasdaq: AVXS) announced a single-arm design for its pivotal study of AVXS-101 in spinal muscular atrophy Type 1 patients.
On the downside
Myriad Genetics (Nasdaq: MYGN) fell to a greater than expected loss for the first quarter.
DexCom (Nasdaq: DXCM) reported a wider than expected loss for the third quarter.
Third quarter revenue for Paycom Software (NYSE: PAYC) missed analyst expectations.
In the broad market, declining issues outpaced advancers by nearly 7 to 2 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 tumbled 13 points to 2,097. Bitcoin slipped $2 to $720.
